Mortality News and Research

RSS

Development of a safe and effective COVID-19 nanoparticle vaccine

Researchers from ReVacc scientific have attempted to demonstrate the effectiveness of a new vaccine, REVC-128, two weeks post-administration.

22 Oct 2021

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

A recent study from the United Kingdom, published in the open-access journal Vaccines, implies that vaccinating adolescents and children may be pivotal in reducing infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as ensuing coronavirus disease (COVID-19) morbidity and mortality across all age groups.

21 Oct 2021

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).

21 Oct 2021

Targeted drug shows promising activity in kidney cancer patients with brain metastases

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet need.

21 Oct 2021

Mental health problems are common among smokers and adults with substance use disorders, study finds

Mental health problems are common among adults who smoke cigarettes and those with substance use disorders, illustrating a need for treating smoking and mental health problems together, according to a new study by Indiana University.

21 Oct 2021

Novel trial uses a virtual village to treat HIV-associated loneliness

A new clinical trial designed by Maile Young Karris, MD, internal medicine physician and infectious disease specialist at UC San Diego Health, seeks to discover whether people living with HIV can benefit from emotional support offered by a virtual community, and from physical support and services delivered by community volunteers.

21 Oct 2021

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

In a recent study, researchers compared the efficacy of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines against infection SARS-CoV-2.

21 Oct 2021

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

The current study included the national response of Denmark and Sweden to the COVID-19 pandemic.

21 Oct 2021

U.S. life expectancy may drop for the second year, minorities most affected

Scientists estimate the effect of the pandemic on life expectancy at birth, at 65 years overall, as well as for individual populations.

21 Oct 2021

$Extra dairy intake lowers risk of falls and fractures among older adults in residential care$

Extra dairy intake lowers risk of falls and fractures among older adults in residential care

Increasing intake of foods rich in calcium and protein such as milk, yogurt, and cheese, reduces falls and fractures in older adults living in residential care, finds a randomized controlled trial published by The BMJ today.

21 Oct 2021

Study: Covid-19 vaccine is over 90% effective at preventing deaths from Delta

Vaccination is over 90 per cent effective at preventing deaths from the Delta variant of Covid-19, according to the first country-level data on mortality.

21 Oct 2021

Yale Cancer Center receives $6.5 million NIH grant for cellular senescence research

The National Institutes of Health has awarded a grant to fund cellular senescence research in lymphoid organs at Yale Cancer Center.

21 Oct 2021

Discovery could lead to new treatments for axial spondyloarthritis

In a paper published today in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute, part of University Health Network in Toronto, have made a discovery that could lead to new treatments for axial spondyloarthritis (SpA), a painful and debilitating form of arthritis which affects 1-2% of Canadians and causes inflammation in the spine, joints, eyes, gut and skin.

20 Oct 2021

Mortality News and Research

Development of a safe and effective COVID-19 nanoparticle vaccine

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

Targeted drug shows promising activity in kidney cancer patients with brain metastases

Mental health problems are common among smokers and adults with substance use disorders, study finds

Novel trial uses a virtual village to treat HIV-associated loneliness

Comparative effectiveness of ChAdOx1 and BNT162b2 COVID-19 vaccines

Comparison of social distancing policies in Denmark and Sweden to combat COVID-19

U.S. life expectancy may drop for the second year, minorities most affected

Extra dairy intake lowers risk of falls and fractures among older adults in residential care

Study: Covid-19 vaccine is over 90% effective at preventing deaths from Delta

Yale Cancer Center receives $6.5 million NIH grant for cellular senescence research

Discovery could lead to new treatments for axial spondyloarthritis

How the public views COVID-19 vaccines via Twitter in the United States

Using hydrogel barriers to effectively prevent post-surgical adhesions

Depression, anxiety in pregnant women may increase the likelihood of cesarean deliveries

Discovery could help develop a new treatment strategy for patients with melanoma

New research on phagocytosis and SARS-CoV-2's spike protein

New oligomer shows promising anti-SARS-CoV-2 properties

Scientists search for cause of mysterious covid-related inflammation in children

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News